10:22 AM EDT, 06/03/2025 (MT Newswires) -- Renovaro ( RENB ) said Tuesday that its BioSymetrics unit received a notice of allowance from the US Patent and Trademark Office for a new patent application.

The patent protects novel methods for integrating and harmonizing diverse biomedical data sources in a framework for predictive modeling, according to Renovaro ( RENB ).

Shares of the company jumped 8.8% in recent trading.

Price: 0.33, Change: +0.04, Percent Change: +14.94